Evidence map›Paper›PMID 24086735›Full record

ArticlePloS one2013

LdFlabarin, a new BAR domain membrane protein of Leishmania flagellum.

Michèle Lefebvre, Emmanuel Tetaud, Magali Thonnus, Bénédicte Salin, Fanny Boissier, Corinne Blancard, Cécile Sauvanet, Christelle Metzler, Benoît Espiau, Annelise Sahin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Cellular landmarks of Trypanosoma brucei and Leishmania mexicana.Molecular and biochemical parasitology · 2019
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Michèle LefebvreCNRS UMR 5290, Montpellier, France ; Université Montpellier 1, Montpellier, France ; Centre Hospitalier Universitaire La Colombière, Montpellier, France ; IRD 224, Montpellier, France.
Emmanuel Tetaud
Magali Thonnus
Bénédicte Salin
Fanny Boissier
Corinne Blancard
Cécile Sauvanet
Christelle Metzler
Benoît Espiau
Annelise Sahin
Gilles Merlin
Centre National de la Recherche Scientifique · FRUniversité de Bordeaux · FRInstitut de Biochimie et Génétique Cellulaires · FRUniversité de Montpellier · FRUniversity of French Polynesia · PF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the Leishmania life cycle, the flagellum undergoes successive assembly and disassembly of hundreds of proteins. Understanding these processes necessitates the study of individual components. Here, we investigated LdFlabarin, an uncharacterized L. donovani flagellar protein. The gene is conserved within the Leishmania genus and orthologous genes only exist in the Trypanosoma genus. LdFlabarin associates with the flagellar plasma membrane, extending from the base to the tip of the flagellum as a helicoidal structure. Site-directed mutagenesis, deletions and chimera constructs showed that LdFlabarin flagellar addressing necessitates three determinants: an N-terminal potential acylation site and a central BAR domain for membrane targeting and the C-terminal domain for flagellar specificity. In vitro, the protein spontaneously associates with liposomes, triggering tubule formation, which suggests a structural/morphogenetic function. LdFlabarin is the first characterized Leishmania BAR domain protein, and the first flagellum-specific BAR domain protein.

Indexed as

Evolution, MolecularPhylogenyBase SequenceComputational BiologyFlagellaLeishmaniaLiposomesMembrane ProteinsMolecular Sequence DataMutagenesis, Site-DirectedProtein BindingProtein Structure, TertiarySequence Analysis, DNALiposomesMembrane Proteins

Identifiers

PMID24086735
PMCPMC3785460
OpenAlexW2088307428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.